List of Tables:

Table 1. Snapshot of Asia Pacific Minimal Residual Disease Testing Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Minimal Residual Disease Testing Market 33
Table 5. Asia Pacific Minimal Residual Disease Testing Market by Offering, 2021-2031, $ mn 41
Table 6. Asia Pacific Minimal Residual Disease Testing Market by Application, 2021-2031, $ mn 45
Table 7. Asia Pacific Minimal Residual Disease Testing Market: Non-Hodgkins Lymphoma (NHL) by Type, 2021-2031, $ mn 48
Table 8. Asia Pacific Minimal Residual Disease Testing Market by Technology, 2021-2031, $ mn 63
Table 9. Main Vendors and Products of Flow Cytometry Technology 65
Table 10. Main Vendors and Products of Polymerase Chain Reaction (PCR) Technology 66
Table 11. Main Vendors and Products of Next-Generation Sequencing (NGS) Technology 67
Table 12. Asia Pacific Minimal Residual Disease Testing Market by End User, 2021-2031, $ mn 69
Table 13. APAC Minimal Residual Disease Testing Market by Country, 2021-2031, $ mn 76
Table 14. Japan Minimal Residual Disease Testing Market by Application, 2021-2031, $ mn 80
Table 15. Japan Minimal Residual Disease Testing Market by Technology, 2021-2031, $ mn 80
Table 16. Japan Minimal Residual Disease Testing Market by End User, 2021-2031, $ mn 80
Table 17. China Minimal Residual Disease Testing Market by Application, 2021-2031, $ mn 82
Table 18. China Minimal Residual Disease Testing Market by Technology, 2021-2031, $ mn 82
Table 19. China Minimal Residual Disease Testing Market by End User, 2021-2031, $ mn 82
Table 20. Australia Minimal Residual Disease Testing Market by Application, 2021-2031, $ mn 85
Table 21. Australia Minimal Residual Disease Testing Market by Technology, 2021-2031, $ mn 85
Table 22. Australia Minimal Residual Disease Testing Market by End User, 2021-2031, $ mn 85
Table 23. India Minimal Residual Disease Testing Market by Application, 2021-2031, $ mn 87
Table 24. India Minimal Residual Disease Testing Market by Technology, 2021-2031, $ mn 87
Table 25. India Minimal Residual Disease Testing Market by End User, 2021-2031, $ mn 87
Table 26. South Korea Minimal Residual Disease Testing Market by Application, 2021-2031, $ mn 89
Table 27. South Korea Minimal Residual Disease Testing Market by Technology, 2021-2031, $ mn 89
Table 28. South Korea Minimal Residual Disease Testing Market by End User, 2021-2031, $ mn 89
Table 29. Minimal Residual Disease Testing Market in Rest of APAC by Country/Region, 2021-2031, $ mn 91
Table 30. Breakdown of World Market by Key Vendor, 2021, % 94
Table 31. Approved and Launched MRD Testing Products of Key Vendors 94
Table 32. Adaptive Biotechnologies Corporation: Company Snapshot 97
Table 33. Adaptive Biotechnologies Corporation: Business Segmentation 98
Table 34. Adaptive Biotechnologies Corporation: Product Portfolio 98

LIST OF FIGURE

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Asia Pacific Minimal Residual Disease Testing Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Minimal Residual Disease Testing Market 24
Figure 7. World Number of Deaths from Cancers in 201 27
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 28
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Minimal Residual Disease Testing Market 30
Figure 11. Investment Opportunity Analysis 34
Figure 12. Porters Fiver Forces Analysis of Asia Pacific Minimal Residual Disease Testing Market 37
Figure 13. Breakdown of Asia Pacific Minimal Residual Disease Testing Market by Offering, 2021-2031, % of Revenue 42
Figure 14. Asia Pacific Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%) 42
Figure 15. Asia Pacific Minimal Residual Disease Testing Market by Offering: Services, 2021-2031, $ mn 43
Figure 16. Asia Pacific Minimal Residual Disease Testing Market by Offering: Test Kits & Consumables, 2021-2031, $ mn 44
Figure 17. Breakdown of Asia Pacific Minimal Residual Disease Testing Market by Application, 2021-2031, % of Sales Revenue 46
Figure 18. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 46
Figure 19. Asia Pacific Minimal Residual Disease Testing Market by Application: Non-Hodgkins Lymphoma (NHL), 2021-2031, $ mn 47
Figure 20. Asia Pacific Minimal Residual Disease Testing Market by Non-Hodgkins Lymphoma (NHL): DLBCL, 2021-2031, $ mn 49
Figure 21. Asia Pacific Minimal Residual Disease Testing Market by Non-Hodgkins Lymphoma (NHL): Marginal Zone Lymphoma, 2021-2031, $ mn 50
Figure 22. Asia Pacific Minimal Residual Disease Testing Market by Non-Hodgkins Lymphoma (NHL): Follicular Lymphoma, 2021-2031, $ mn 51
Figure 23. Asia Pacific Minimal Residual Disease Testing Market by Non-Hodgkins Lymphoma (NHL): Peripheral T-cell Lymphoma, 2021-2031, $ mn 52
Figure 24. Asia Pacific Minimal Residual Disease Testing Market by Non-Hodgkins Lymphoma (NHL): Mantle Cell Lymphoma, 2021-2031, $ mn 53
Figure 25. Asia Pacific Minimal Residual Disease Testing Market by Non-Hodgkins Lymphoma (NHL): Other NHLs, 2021-2031, $ mn 54
Figure 26. Asia Pacific Minimal Residual Disease Testing Market by Application: Multiple Myeloma (MM), 2021-2031, $ mn 55
Figure 27. Asia Pacific Minimal Residual Disease Testing Market by Application: Acute Lymphoblastic Leukemia (ALL), 2021-2031, $ mn 56
Figure 28. Asia Pacific Minimal Residual Disease Testing Market by Application: Chronic Lymphoblastic Leukemia (CLL), 2021-2031, $ mn 57
Figure 29. Asia Pacific Minimal Residual Disease Testing Market by Application: Acute Myeloid Leukemia (AML), 2021-2031, $ mn 58
Figure 30. Asia Pacific Minimal Residual Disease Testing Market by Application: Chronic Myeloid Leukemia (CML), 2021-2031, $ mn 59
Figure 31. Asia Pacific Minimal Residual Disease Testing Market by Application: Hodgkins Lymphoma (HL), 2021-2031, $ mn 60
Figure 32. Asia Pacific Minimal Residual Disease Testing Market by Application: Solid Tumor, 2021-2031, $ mn 61
Figure 33. Asia Pacific Minimal Residual Disease Testing Market by Application: Other Applications, 2021-2031, $ mn 62
Figure 34. Breakdown of Asia Pacific Minimal Residual Disease Testing Market by Technology, 2021-2031, % of Sales Revenue 64
Figure 35. Asia Pacific Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 64
Figure 36. Asia Pacific Minimal Residual Disease Testing Market by Technology: Flow Cytometry, 2021-2031, $ mn 65
Figure 37. Asia Pacific Minimal Residual Disease Testing Market by Technology: Polymerase Chain Reaction (PCR), 2021-2031, $ mn 66
Figure 38. Asia Pacific Minimal Residual Disease Testing Market by Technology: Next-Generation Sequencing (NGS), 2021-2031, $ mn 67
Figure 39. Asia Pacific Minimal Residual Disease Testing Market by Technology: Other Technologies, 2021-2031, $ mn 68
Figure 40. Breakdown of Asia Pacific Minimal Residual Disease Testing Market by End User, 2021-2031, % of Revenue 70
Figure 41. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 70
Figure 42. Asia Pacific Minimal Residual Disease Testing Market by End User: Hospitals and Clinics, 2021-2031, $ mn 71
Figure 43. Asia Pacific Minimal Residual Disease Testing Market by End User: Research Institutions, 2021-2031, $ mn 72
Figure 44. Asia Pacific Minimal Residual Disease Testing Market by End User: Diagnostic Laboratories, 2021-2031, $ mn 73
Figure 45. Asia Pacific Minimal Residual Disease Testing Market by End User: Other End Users, 2021-2031, $ mn 74
Figure 46. Breakdown of APAC Minimal Residual Disease Testing Market by Country, 2021 and 2031, % of Revenue 76
Figure 47. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 77
Figure 48. Minimal Residual Disease Testing Market in Japan, 2021-2031, $ mn 79
Figure 49. Minimal Residual Disease Testing Market in China, 2021-2031, $ mn 81
Figure 50. Minimal Residual Disease Testing Market in Australia, 2021-2031, $ mn 83
Figure 51. Minimal Residual Disease Testing Market in India, 2021-2031, $ mn 86
Figure 52. Minimal Residual Disease Testing Market in South Korea, 2021-2031, $ mn 88
Figure 53. Minimal Residual Disease Testing Market in Rest of APAC, 2021-2031, $ mn 90
Figure 54. Growth Stage of Asia Pacific Minimal Residual Disease Testing Industry over the Forecast Period 92